Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06399705 · ClinicalTrials.gov registry record · Phase 3
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
A Phase 3 study of Coronary Artery Disease, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 600
- Enrollment target
- 18
- Study locations
NCT06399705: Recruiting Phase 3 study of Coronary Artery Disease, sponsored by Weill Medical College of Cornell University.
NCT06399705 is a Phase 3 study of Coronary Artery Disease that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 600 participants, below the 1,284-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (53% lower). The trial reports 18 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06399705, a Phase 3 study of Coronary Artery Disease, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 600 participants
- Enrollment target
- 18
- Study locations
Study Summary
This is a research study in minorities to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is an open-heart operation in which healthy blood vessels from inside the chest, leg, and/or forearm are used to "bypass" the blockages (like a detour). Outcomes will be measured by comparing survival and improvement in quality-of-life.
Primary Outcome
Generic quality of life (QOL) will be assessed by utilizing the 12-item Short Form Survey (SF-12v2). The score ranges from 1-100, with higher scores indicating a better health status. The win ratio will be used
Conditions Studied
Interventions
- PROCEDURE Coronary artery bypass grafting
- PROCEDURE Percutaneous coronary intervention
Study Locations (18)
New York
- NewYork-Presbyterian Hospital - Queens - Flushing
- Icahn School of Medicine - Mount Sinai Morningside - New York
- Icahn School of Medicine - Mount Sinai Hospital - New York
- Columbia University Irving Medical Center/NewYork-Presbyterian Hospital - New York
- Weill Cornell Medicine/NewYork-Presbyterian Hospital - New York
- Westchester Medical Center - Valhalla
Kentucky
- Baptist Health Lexington - Lexington
- Baptist Health Louisville - Louisville
Tennessee
- Methodist Le Bonheur Healthcare - Memphis
- Ascension Saint Thomas Hospital - Nashville
California
- Adventist Health Glendale - Glendale
Georgia
- Emory University - Atlanta
Indiana
- Ascension St. Vincent Cardiovascular Research Institute - Carmel
Massachusetts
- Massachusetts General Hospital - Boston
New Jersey
- Englewood Hospital - Englewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2024-10-02 |
| Est. Completion | 2039-01-01 |
| Phase | Phase 3 |
What NCT06399705 shows while recruiting
NCT06399705 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 1,284-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (53% lower).
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Coronary artery bypass grafting is the first listed.
NCT06399705 lists 18 locations in 11 states (New York, Kentucky, Tennessee).
Frequently Asked Questions
What is clinical trial NCT06399705 about?
NCT06399705 is a clinical study titled "REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities". This is a research study in minorities to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is ...
What is the current status of trial NCT06399705?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 600 participants. The study started on 2024-10-02. Estimated completion is 2039-01-01.
What conditions does trial NCT06399705 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
What interventions are being tested in trial NCT06399705?
The interventions under investigation include: Coronary artery bypass grafting (PROCEDURE), Percutaneous coronary intervention (PROCEDURE).
Who is sponsoring clinical trial NCT06399705?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06399705 being conducted?
This trial has 18 study locations across California, Georgia, Indiana, Kentucky, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06399705's enrollment target sits among peer trials
600 67th of 219 higher than 151 of 219 other Coronary Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque
RECRUITING · Phase 3
-
RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)
RECRUITING · Phase 3
-
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
RECRUITING · Phase 3
-
PANDORA: Delirium Prevention After Cardiac Surgery Using IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients
ACTIVE NOT RECRUITING · Phase 3
-
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
ACTIVE NOT RECRUITING · Phase 3
-
Cardiovascular Outcomes Of Diet Counseling
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI